The influx of immigrant children under HHS' care translates into big contracts for providers charged with the children's medical treatment.
Dr. Atul Gawande will lead the Boston-based Amazon, Berkshire Hathaway and JPMorgan Chase healthcare venture, the companies announced Wednesday.
As a thought leader with a trifecta of medical expertise, policy prowess and communication skills, Dr. Atul Gawande is seen as an ideal pick to lead the joint venture. But his other responsibilities and limited business background could stymie his impact.
The House passed two hospital-backed opioid bills to loosen the Medicaid funding restrictions on residential facilities for opioid addicts and to allow providers to share patient medical history that shows addiction.
The U.S. House of Representatives will create a new oversight panel to monitor the VA's $10 billion implementation of a Cerner EHR. The VA has faced scrutiny over the planned overhaul of its EHR system since the project was announced over a year ago.
Antitrust experts and healthcare provider representatives questioned the promised benefits of a proposed merger between pharmacy chain CVS Health and insurer Aetna during a hearing before the California insurance commissioner.
The CMS has issued a request for information to review how it can reduce the burden around the controversial Stark law. Providers claim the law has slowed the move to value-based care.
Regulators and insurance experts worry the Trump administration's new rule expanding association health plans will spark a surge of insurance fraud and insolvencies that plagued consumers and healthcare providers in the past.
The CMS has submitted a series of legislative ideas to Congress they say would better coordinate care for people eligible for both Medicare and Medicaid. These beneficiaries tend to be sicker and more expensive to manage.
Integris Health has chosen Timothy Pehrson as its next CEO. Pehrson most recently served as Intermountain Healthcare's regional vice president and vice president of continuous improvement.
Almost all healthcare organizations surveyed by EY are either in the process of adopting new technology or are planning on doing so in the next year.
A new study published Tuesday shows hospitals aren't fully relying on medications to treat opioid use disorder. Experts say that's a missed opportunity to expand treatment to thousands of people.